Retour sur lavenir.net
   PROXIMUS 6.265 € (-1,88 %)     RECTICEL 10.540 € (-1,68 %)     TUBIZE-FIN 216.600 € (-0,46 %)     AEDIFICA 69.100 € (-0,22 %)     KBC 119.000 € (+1,06 %)     AB INBEV 71.700 € (+0,73 %)     ARGENX SE 767.600 € (+1,56 %)     AZELIS GROUP 9.940 € (-2,17 %)     SYENSQO 68.350 € (+0,59 %)     GIMV 44.650 € (-1,00 %)     COFINIMMO 81.100 € (-0,61 %)     AGFA-GEVAERT 0.422 € (-1,17 %)     ONWARD MEDICAL 2.670 € (+1,52 %)     MELEXIS 81.050 € (+1,12 %)     BANQUP GROUP 1.745 € (+2,65 %)     CMB.TECH 13.040 € (+0,46 %)     UMICORE 23.780 € (-0,92 %)     SOFINA 220.000 € (+0,18 %)     XIOR 26.050 € (-0,38 %)     JENSEN-GROUP 82.400 € (-1,90 %)     FAGRON 23.700 € (-0,84 %)     HYLORIS 4.620 € (+0,43 %)     WDP 21.880 € (-0,55 %)     MONTEA 66.100 € (-0,75 %)     UCB 250.500 € (+0,20 %)     RETAIL ESTATES 69.200 € (-0,43 %)     SOLVAY 27.480 € (+0,66 %)     IBA 16.800 € (+4,74 %)     D'IETEREN GROUP 167.300 € (-0,42 %)     KBC ANCORA 81.600 € (+1,24 %)     BARCO 8.675 € (+0,93 %)     DEME GROUP 183.600 € (-0,86 %)     ELIA GROUP 132.000 € (-1,42 %)     BPOST 1.646 € (-1,56 %)     COLRUYT 34.520 € (+0,47 %)     INCLUSIO SA/NV 16.900 € (0,00 %)     ASCENCIO 52.000 € (-1,52 %)     ECONOCOM GROUP 1.555 € (+0,32 %)     EKOPAK 4.000 € (+2,04 %)     LOTUS BAKERIES 11 260.000 € (+0,18 %)     EVS 29.750 € (-0,17 %)     VASTNED 29.500 € (-0,17 %)     CARE PROPERTY INV. 12.380 € (-0,48 %)     KINEPOLIS GROUP 35.150 € (-1,13 %)     VGP 80.900 € (-1,94 %)     NYXOAH 1.430 € (+2,29 %)     ACKERMANS V.HAAREN 285.000 € (0,00 %)     BREDERODE 102.800 € (-0,96 %)     GBL 78.900 € (-0,44 %)     WAREHOUSES ESTATES 40.400 € (-1,46 %)     DECEUNINCK 2.325 € (+0,43 %)     ONTEX GROUP 2.390 € (-3,63 %)     BIOTALYS 3.180 € (+0,32 %)     ORANGE BELGIUM 21.500 € (0,00 %)     AGEAS 67.200 € (-0,37 %)     TITAN S.A. 53.750 € (+1,70 %)     SOFTIMAT 0.890 € (0,00 %)     CENERGY 23.940 € (-2,21 %)     VIOHALCO 19.100 € (-0,83 %)     CAMPINE 227.000 € (-0,44 %)  
   FDJ UNITED 22.560 € (-0,53 %)     2CRSI 44.400 € (-3,01 %)     LEGRAND 145.350 € (+4,79 %)     CVC CAPITAL 13.410 € (+0,37 %)     J.MARTINS,SGPS 17.690 € (+0,11 %)     KERING 266.350 € (+0,38 %)     LVMH 520.100 € (-0,04 %)     DSM FIRMENICH AG 73.520 € (+0,33 %)     PUBLICIS GROUPE SA 92.340 € (+0,24 %)     SANOFI 75.010 € (-0,86 %)     IMCD 85.380 € (-0,79 %)     STELLANTIS NV 5.850 € (-2,06 %)     NN GROUP 73.880 € (-0,86 %)     WORLDLINE 11.832 € (-10,09 %)     CREDIT AGRICOLE 17.375 € (+0,78 %)     ENGIE 26.570 € (-1,23 %)     ING GROEP N.V. 27.090 € (+0,89 %)     PROSUS 39.135 € (+0,86 %)     BE SEMICONDUCTOR 307.800 € (+2,98 %)     NANOBIOTIX 29.660 € (-2,11 %)     ASM INTERNATIONAL 1 029.000 € (+4,17 %)     CTP 15.520 € (-0,64 %)     TELEPERFORMANCE 56.680 € (+2,02 %)     CELLECTIS 2.684 € (-0,22 %)     ANTIN INFRA PARTN 9.220 € (-2,95 %)     AIRBUS 186.460 € (+0,63 %)     SCHNEIDER ELECTRIC 284.400 € (+2,69 %)     STMICROELECTRONICS 65.860 € (+0,27 %)     SES 7.385 € (-0,20 %)     ASML HOLDING 1 629.200 € (+2,39 %)     DANONE 65.900 € (-0,45 %)     AKZO NOBEL 58.880 € (+0,48 %)     THALES 230.700 € (+1,14 %)     B.COM.PORTUGUES 1.012 € (+2,45 %)     ARCELORMITTAL SA 58.060 € (-1,96 %)     GECINA 73.450 € (-1,08 %)     SOCIETE GENERALE 77.850 € (+0,87 %)     CSG 14.814 € (+4,13 %)     CAPGEMINI 98.300 € (+0,72 %)     ADYEN 899.100 € (+0,99 %)     AHOLD DEL 35.660 € (-1,52 %)     MEDINCELL 24.500 € (-12,56 %)     EDP RENEWABLES 13.280 € (-1,48 %)     VENTE UNIQUE.COM 15.400 € (+1,99 %)     BOUYGUES 49.970 € (-1,09 %)     SAFRAN 325.600 € (+0,49 %)     HEINEKEN HOLDING 64.100 € (+0,31 %)     AEGON 7.424 € (-0,85 %)     BNP PARIBAS ACT.A 100.700 € (+0,74 %)     SAINT GOBAIN 79.400 € (+1,15 %)     ABN AMRO BANK N.V. 36.890 € (+1,93 %)     ESSILORLUXOTTICA 178.200 € (-2,91 %)     TOTALENERGIES 72.640 € (-0,56 %)     HERMES INTL 1 742.000 € (-0,43 %)     AIR LIQUIDE 167.380 € (0,00 %)     BUREAU VERITAS 26.185 € (+0,06 %)     CARREFOUR 16.345 € (-1,63 %)     VINCI 129.500 € (+0,23 %)     GETLINK SE 18.380 € (-0,97 %)     PLUXEE 11.200 € (-0,27 %)  
News Réglementées
08/02/2023 13:49

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

The Vanguard Group, Inc. ( IRSH)
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

08-Feb-2023 / 12:49 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


Ap27

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

  1.         Full name of discloser

The Vanguard Group, Inc.

  1.         Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

  1.         Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

Horizon Therapeutics plc

  1.         If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

 

  1.         Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

06 February 2023

  1.           In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

N/A

 

2. INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

 

Ap28

 

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

Class of relevant security
(Note 3)

US$0.0001 ordinary shares

 

Interests

Short positions

Number

%

Number

%

  1. Relevant securities owned and/or controlled

21,301,978

9.31%

 

 

  1. Cash-settled derivatives

 

 

 

 

  1. Stock-settled derivatives (including options) and agreements to purchase/ sell

 

 

 

 

Total

21,301,978

9.31%

 

 

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit
(Note 5)

US$0.0001 ordinary shares

Purchase

369

110.12 USD

US$0.0001 ordinary shares

Purchase

2,716

110.25 USD

US$0.0001 ordinary shares

Sale

1,110

110.25 USD

 

 

 

Ap29

 

(b) Cash-settled derivative transactions

 

Class of
relevant
security

Product
description
e.g. CFD

Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of
reference
securities
(Note 6)

Price
per unit
(Note 5)

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of
relevant
security

Product
description e.g. call
option

Writing, purchasing, selling, varying
etc.

Number
of
securities
to which
option
relates
(Note 6)

Exercise
price per
unit

Type
e.g.
American,
European
etc.

Expiry
date

Option
money
paid/
received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of
relevant
security

Product
description
e.g. call
option

Exercising/
exercised
against

Number of
securities

Exercise
price per
unit
(Note 5)

  

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of
relevant
security

Nature of dealing
e.g. subscription,
conversion, exercise

Details

Price per unit (if
applicable)
(Note 5)

 Not Applicable

 

 

 

 

Ap30

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière